Name: Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (IgG-Fv)
SKU: BSGV-137
Rating: 5 (1 reviews)

Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CEA antibody variable domain is fused to the C terminal of an IgG of anti-DTPA antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can be used in pretargeting system of PET, radioimaging or radiotherapy. It can mediate targeting of radioactivity to tumor cells. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer imaging and therapy.

Datasheet INQUIRY

Specifications

Targets

CEA & DTPA

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Pretargeting system for radioimaging and radiotherapy

Related Disease

Breast cancer; Ovary cancer; Colon cancer; Lung cancer

Targets

Target 1

CEA

Gene ID

1048

UniProt ID

A0A024R0K5

Alternative Names

CEACAM5; carcinoembryonic antigen; carcinoembryonic antigen related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100

Target 2

DTPA

Alternative Names

diethylenetriaminepentaacetic acid; DTPA; pentetic acid

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (IgG-Fv) (BSGV-137). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (IgG-Fv) (CAT#: BSGV-137)

Specifications

Targets

Customer Reviews and Q&As